Drug survival in patients with psoriasis is associated with the availability of biologic medications.
G ShalomArnon D CohenI FeldhamerD ComaneshterT FreudL PavlovskyPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Different drug survival rates between ustekinumab and secukinumab are determined by the treatment line and calendar year, reflecting the availability of biologic medications, and not only by the biologic attributes of each medication.